Home > Innovation

CnS Healthtech

Company Profile

CnS Healthtech is a health technology company originating from the research ecosystem of the National University of Singapore and incubated at the NUS Guangzhou Research Translation & Innovation Institute. The company focuses on the research, development, and production of functional ingredients with clearly defined scientific mechanisms and verifiable efficacy, providing long-term, high-value core ingredient solutions for the cosmetics and health industries.



1768809821185743.jpg


Product Features

CnS Healthtech’s core products are derived from a functional extraction platform based on Schizosaccharomyces pombe, built upon over 20 years of systematic research. Through sustained exploration of cell division and cellular health, oxidative imbalance, aging, and cellular repair mechanisms, the company has established an ingredient platform characterized by natural origin, safety, and high biological activity, serving applications in skincare and nutritional health.


Corporate Philosophy

CnS Healthtech pioneers and practices the concept of “Live-Cell Visualization for Skincare.” By leveraging live-cell imaging technologies, the company directly and dynamically monitors, at the cellular level, changes in cell vitality, antioxidant status, and aging-related indicators in skin-relevant cells. Moving beyond ingredient lists and conceptual claims, CnS Healthtech directly observes how living cells respond to functional ingredients. Supported by long-standing expertise in live-cell scientific visualization, the company precisely characterizes and validates the mechanisms of action and efficacy of its ingredients and formulations, ensuring that product performance is mechanistically grounded, evidence-based, and visually demonstrable—truly making the real effects of skincare ingredients visible.

We believe that genuinely valuable skincare and health products must withstand rigorous validation at the cellular level.


1768809888355057.jpg


Company Development

CnS Healthtech has established a full-chain R&D capability spanning synthetic biology-based strain engineering, novel ingredient discovery, target and mechanism validation, and product development and translation. The core team brings together expertise in fission yeast and functional fermentation research, live-cell microscopy and imaging, cell and molecular biology, clinical medicine, and industrial and capital operations, combining deep scientific insight with a clear understanding of market expectations for long-term value and authentic efficacy, and providing a solid foundation for continuous innovation and commercialization.

 



Other incubated enterprises

Contact Us